| Dr Reagan Wei Quan, MD | |
|
44055 Riverside Pkwy Ste 226, Leesburg, VA 20176-5177 | |
| (703) 970-2670 | |
| (703) 970-0240 |
| Full Name | Dr Reagan Wei Quan |
|---|---|
| Gender | Male |
| Speciality | Vascular Surgery |
| Experience | 26 Years |
| Location | 44055 Riverside Pkwy Ste 226, Leesburg, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487788956 | NPI | - | NPPES |
| 2897463 | Other | PA | HIGHMARK BLUE SHIELD |
| 67564400 | Medicaid | MD | |
| 420534 | Other | PA | UPMC |
| 102832761 | Medicaid | PA | |
| 30158392 | Other | PA | AMERIHEALTH CARITAS - WMG |
| Facility Name | Location | Facility Type |
|---|---|---|
| Inova Loudoun Hospital | Leesburg, VA | Hospital |
| Inova Fairfax Hospital | Falls church, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Inova Health Care Services | 2466351093 | 1725 |
| Inova Health Care Services | 2466351093 | 1725 |
News Archive
Porvair Filtration Group has announced the launch of the first product, a ChIP kit containing 24 assays, based upon its novel Chromatrap™ Pro-A Chromatin ImmunoPrecipitation (ChIP) technology. The exciting new product has been enthusiastically tested at 12 beta sites around the world with excellent results and feedback.
Engineers at Ruhr-Universität Bochum have developed a new statistical model that predicts how likely extreme flood events are in Germany.
Scientists have made a major breakthrough in understanding the genetics of the insect parasite that is being targeted by researchers as a way of preventing the spread of malaria.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that senior members of its management will be presenting at upcoming conferences and will highlight critical aspects of the development of RXi's next generation rxRNA™ therapeutic platform as well as specific preclinical data generated with this platform.
Matthew Feddersen and Blake Marggraff from Lafayette, Calif. were awarded the top prize at the Intel International Science and Engineering Fair, a program of Society for Science & the Public. They received $75,000 and the Gordon E. Moore Award, in honor of the Intel co-founder and retired chairman and CEO, for developing a potentially more effective and less expensive cancer treatment that places tin metal near a tumor before radiation therapy.
› Verified 4 days ago
| Entity Name | Inova Health Care Services |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1952320061 PECOS PAC ID: 2466351093 Enrollment ID: O20110104000409 |
News Archive
Porvair Filtration Group has announced the launch of the first product, a ChIP kit containing 24 assays, based upon its novel Chromatrap™ Pro-A Chromatin ImmunoPrecipitation (ChIP) technology. The exciting new product has been enthusiastically tested at 12 beta sites around the world with excellent results and feedback.
Engineers at Ruhr-Universität Bochum have developed a new statistical model that predicts how likely extreme flood events are in Germany.
Scientists have made a major breakthrough in understanding the genetics of the insect parasite that is being targeted by researchers as a way of preventing the spread of malaria.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that senior members of its management will be presenting at upcoming conferences and will highlight critical aspects of the development of RXi's next generation rxRNA™ therapeutic platform as well as specific preclinical data generated with this platform.
Matthew Feddersen and Blake Marggraff from Lafayette, Calif. were awarded the top prize at the Intel International Science and Engineering Fair, a program of Society for Science & the Public. They received $75,000 and the Gordon E. Moore Award, in honor of the Intel co-founder and retired chairman and CEO, for developing a potentially more effective and less expensive cancer treatment that places tin metal near a tumor before radiation therapy.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Reagan Wei Quan, MD Po Box 37174, Baltimore, MD 21297-3174 Ph: (571) 423-5699 | Dr Reagan Wei Quan, MD 44055 Riverside Pkwy Ste 226, Leesburg, VA 20176-5177 Ph: (703) 970-2670 |
News Archive
Porvair Filtration Group has announced the launch of the first product, a ChIP kit containing 24 assays, based upon its novel Chromatrap™ Pro-A Chromatin ImmunoPrecipitation (ChIP) technology. The exciting new product has been enthusiastically tested at 12 beta sites around the world with excellent results and feedback.
Engineers at Ruhr-Universität Bochum have developed a new statistical model that predicts how likely extreme flood events are in Germany.
Scientists have made a major breakthrough in understanding the genetics of the insect parasite that is being targeted by researchers as a way of preventing the spread of malaria.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that senior members of its management will be presenting at upcoming conferences and will highlight critical aspects of the development of RXi's next generation rxRNA™ therapeutic platform as well as specific preclinical data generated with this platform.
Matthew Feddersen and Blake Marggraff from Lafayette, Calif. were awarded the top prize at the Intel International Science and Engineering Fair, a program of Society for Science & the Public. They received $75,000 and the Gordon E. Moore Award, in honor of the Intel co-founder and retired chairman and CEO, for developing a potentially more effective and less expensive cancer treatment that places tin metal near a tumor before radiation therapy.
› Verified 4 days ago
Cecil Bernard Cross, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 44055 Riverside Pkwy, Suite 246, Leesburg, VA 20176 Phone: 703-858-3200 Fax: 703-858-3203 | |
Michelle Shadi Abghari, M.D Surgery Medicare: Accepting Medicare Assignments Practice Location: 44055 Riverside Pkwy Ste 108, Leesburg, VA 20176 Phone: 703-858-8600 Fax: 703-858-8603 | |
Dr. John Johnson Mcelveen Jr., MD Surgery Medicare: Medicare Enrolled Practice Location: 19441 Golf Vista Plz Ste 230&310, Leesburg, VA 20176 Phone: 703-729-3420 | |
Dr. Yohannes Mahtemework, D.O. Surgery Medicare: Not Enrolled in Medicare Practice Location: 528 Legrace Ter Ne, Leesburg, VA 20176 Phone: 571-484-1535 | |
Dr. Jennifer Lobb, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 44055 Riverside Pkwy Ste 238, Leesburg, VA 20176 Phone: 703-858-8878 | |
Wesley Leroy Harris, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 44045 Riverside Pkwy Ste 100, Leesburg, VA 20176 Phone: 703-858-8878 Fax: 703-858-8170 | |
Rahil Dharia, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 44055 Riverside Pkwy Ste 238, Leesburg, VA 20176 Phone: 703-858-8878 Fax: 703-858-8170 |